What is the recommended treatment for intestinal amoebiasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Intestinal Amoebiasis

Metronidazole 750 mg orally three times daily for 5-10 days is the recommended first-line treatment for intestinal amoebiasis, and must be followed by a luminal amebicide such as paromomycin to eliminate intestinal cysts and prevent relapse. 1, 2, 3

Diagnostic Confirmation Before Treatment

  • Do not treat for amoebiasis unless microscopic examination of fresh feces shows amebic trophozoites, or two different antibiotics given for shigellosis have failed to produce clinical improvement 1, 3
  • Use concentrated stool microscopy or fecal PCR to identify Entamoeba histolytica 2
  • This diagnostic requirement prevents unnecessary treatment and distinguishes amoebiasis from bacterial dysentery, which is more common 1

Two-Phase Treatment Regimen

Phase 1: Tissue Amebicide (Metronidazole)

Adults:

  • Metronidazole 750 mg orally three times daily for 5-10 days 1, 2, 3

Children:

  • Metronidazole 30 mg/kg/day for 5-10 days 1, 3

Phase 2: Luminal Amebicide (Essential to Prevent Relapse)

After completing metronidazole, all patients must receive a luminal agent to eliminate intestinal cysts 2, 3, 4

Options include:

  • Paromomycin 500 mg orally three times daily for 7 days (adults) 2
  • Paromomycin 30 mg/kg/day orally in 3 divided doses for 10 days 3, 4
  • Diloxanide furoate 500 mg orally three times daily for 10 days 2, 3, 4

Note: Paromomycin is FDA-approved for intestinal amoebiasis 5

Alternative: Tinidazole

  • Tinidazole is FDA-approved for intestinal amoebiasis and may offer superior efficacy with better tolerability 6
  • Tinidazole 2 g orally once daily for 3 days showed cure rates of 86-93% in controlled trials 6
  • Research studies demonstrate tinidazole superiority over metronidazole (90-96.5% cure rate vs 53.3-58.6%) with fewer side effects 7, 8, 9
  • However, tinidazole must also be followed by a luminal amebicide 4

Monitoring Treatment Response

  • Clinical improvement should occur within 48 hours of initiating therapy 2
  • If no improvement occurs within 2 days, change antibiotics or refer for stool microscopy to confirm diagnosis 1, 3
  • At this stage, resistant shigellosis remains more likely than amoebiasis if initial diagnosis was uncertain 1

Critical Pitfall to Avoid

Failure to provide a luminal agent after metronidazole or tinidazole therapy is the most common cause of relapse 2, 4

  • Metronidazole and tinidazole are tissue amebicides that treat invasive disease but do not adequately eliminate intestinal cysts 2
  • Without luminal treatment, cysts persist in the intestinal lumen and cause recurrent infection 2, 4
  • This two-phase approach is essential even when follow-up stool microscopy is negative 4

Special Populations

  • Immunocompromised patients receive the same treatment regimen as immunocompetent patients 2
  • The single-dose tinidazole regimen is not effective for asymptomatic cyst carriers due to rapid absorption and short duration 10

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Intestinal Amoebiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Amoebiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amebiasis Intestinal Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tinidazole and metronidazole in the treatment of intestinal amoebiasis.

Current medical research and opinion, 1977

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.